6/14
06:12 am
insm
Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring [Yahoo! Finance]
Medium
Report
Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring [Yahoo! Finance]
6/7
08:05 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a "buy" rating on the stock.
6/7
08:00 am
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/6
09:24 am
insm
Bronchiectasis Opportunity Assessment and 10 Year Forecast 2023-2033 [Yahoo! Finance]
Low
Report
Bronchiectasis Opportunity Assessment and 10 Year Forecast 2023-2033 [Yahoo! Finance]
6/5
08:00 am
insm
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Low
Report
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
5/31
10:13 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $39.00 to $67.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $39.00 to $67.00. They now have a "buy" rating on the stock.
5/30
04:18 pm
insm
Insmed to Host Commercial Webinar on June 4, 2024 [Yahoo! Finance]
Low
Report
Insmed to Host Commercial Webinar on June 4, 2024 [Yahoo! Finance]
5/30
04:05 pm
insm
Insmed to Host Commercial Webinar on June 4, 2024
Medium
Report
Insmed to Host Commercial Webinar on June 4, 2024
5/30
02:52 pm
insm
Insmed announces pricing of $650M public offering [Seeking Alpha]
Low
Report
Insmed announces pricing of $650M public offering [Seeking Alpha]
5/30
08:00 am
insm
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
Medium
Report
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
5/29
01:50 pm
insm
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data [Yahoo! Finance]
Medium
Report
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data [Yahoo! Finance]
5/29
11:10 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at TD Cowen from $45.00 to $67.00. They now have a "buy" rating on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at TD Cowen from $45.00 to $67.00. They now have a "buy" rating on the stock.
5/29
10:16 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $77.00. They now have an "overweight" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $77.00. They now have an "overweight" rating on the stock.
5/29
10:16 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
5/29
10:16 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
5/29
09:11 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Co. from $48.00 to $68.00. They now have a "buy" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Co. from $48.00 to $68.00. They now have a "buy" rating on the stock.
5/29
08:40 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $55.00. They now have an "overweight" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $55.00. They now have an "overweight" rating on the stock.
5/29
08:40 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
High
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
5/29
08:01 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at HC Wainwright from $52.00 to $70.00. They now have a "buy" rating on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at HC Wainwright from $52.00 to $70.00. They now have a "buy" rating on the stock.
5/29
06:36 am
insm
Insmed stocks soar as Phase III lung disease drug exceeds expectations [Yahoo! Finance]
High
Report
Insmed stocks soar as Phase III lung disease drug exceeds expectations [Yahoo! Finance]
5/29
05:29 am
insm
Insmed intends to raise $500M via equity offering [Seeking Alpha]
High
Report
Insmed intends to raise $500M via equity offering [Seeking Alpha]
5/28
06:29 pm
insm
Insmed Announces Proposed $500 Million Public Offering of Common Stock [Yahoo! Finance]
High
Report
Insmed Announces Proposed $500 Million Public Offering of Common Stock [Yahoo! Finance]
5/28
06:21 pm
insm
Insmed Announces Proposed $500 Million Public Offering of Common Stock
Medium
Report
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5/28
03:47 pm
insm
Insmed stock blasts off over lung condition study results [Yahoo! Finance]
Low
Report
Insmed stock blasts off over lung condition study results [Yahoo! Finance]
5/28
01:10 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $40.00 price target on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $40.00 price target on the stock.